The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing

Transl Neurodegener. 2024 Jan 23;13(1):7. doi: 10.1186/s40035-024-00397-x.

Abstract

Ageing is a crucial risk factor for Alzheimer's disease (AD) and is characterised by systemic changes in both intracellular and extracellular microenvironments that affect the entire body instead of a single organ. Understanding the specific mechanisms underlying the role of ageing in disease development can facilitate the treatment of ageing-related diseases, such as AD. Signs of brain ageing have been observed in both AD patients and animal models. Alleviating the pathological changes caused by brain ageing can dramatically ameliorate the amyloid beta- and tau-induced neuropathological and memory impairments, indicating that ageing plays a crucial role in the pathophysiological process of AD. In this review, we summarize the impact of several age-related factors on AD and propose that preventing pathological changes caused by brain ageing is a promising strategy for improving cognitive health.

Keywords: Alzheimer’s disease; Anti-ageing therapy; Brain ageing; Cell senescence; Chronic inflammation; Hallmarks of ageing.

Publication types

  • Review

MeSH terms

  • Aging
  • Alzheimer Disease* / epidemiology
  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / therapy
  • Amyloid beta-Peptides
  • Animals
  • Brain
  • Humans
  • Memory Disorders

Substances

  • Amyloid beta-Peptides